4//SEC Filing
Fromkin Andrew J. 4
Accession 0001764013-23-000156
CIK 0001764013other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:30 PM ET
Size
9.4 KB
Accession
0001764013-23-000156
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Fromkin Drew J
Director
Transactions
- Sale
Common Stock
2023-12-01$39.81/sh−3,636$144,749→ 93,431 total - Sale
Common Stock
2023-12-01$38.78/sh−3,941$152,832→ 97,067 total - Sale
Common Stock
2023-12-01$40.46/sh−4,773$193,116→ 88,658 total
Footnotes (4)
- [F1]Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.19 - $39.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.22 - $40.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.24 - $40.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001341896
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:30 PM ET
- Size
- 9.4 KB